Phynova Group Ltd. is a British life science company specialized in developing and commercialising unique, science-proven health ingredients, powered by plants.
Phynova’s flagship ingredient, Reducose®, is a patented mulberry leaf extract supported by 13+ human clinical studies, demonstrating reductions in post-meal glucose and insulin spikes of up to 42%, and has been commercialized in over 400 million servings globally. Effective at a small serving size of just 250 mg, Reducose® is conveniently taken alongside meals containing carbohydrates and delivers immediate effects, which consumers can observe in real time using continuous glucose monitors (CGMs). It’s also something consumers can feel, as stable post-meal glucose responses are associated with steadier energy, improved focus and sleep, greater satiety, and fewer cravings in the short term. It also supports healthier insulin sensitivity over time.
In 2025, Reducose® was named Botanical Ingredient of the Year at the NutraIngredients-Asia Awards and achieved the rare distinction of being a triple finalist across the NutraIngredients Awards programs in Asia, Europe, and the U.S., highlighting its global recognition.
Fully water-soluble, heat-stable, easily masked, non-GMO verified and simple to formulate with, Reducose® is ideally suited for dietary supplements, functional foods, and beverages, exemplifying Phynova’s platform approach to building premium, science-backed botanical ingredients with lasting commercial value.
For any queries visit our website, call +44 (0)1993 880700 or email info@phynova.com
